Product Information
TROPICAMIDE 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $0.5515 per ML under NDC 61314035502. Its NADAC has been published 498 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
Sandoz Inc.NDC
61314035502
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TROPICAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA084306FDA Approved
Before 1982
TE Code
AT
On Market Since
6/13/2000
Pharmacological Classes
Price Statistics
The NADAC for TROPICAMIDE 1% EYE DROPS has been published 498 times since Nov 28, 2013, and over the history we have for it it has declined 44.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5515 per ML |
|---|---|
| All-time high | $1.3196 (Nov 12, 2014) |
| All-time low | $0.3621 (Mar 22, 2017) |
| 52-week high | $0.5515 |
| 52-week low | $0.4784 |
| Median price | $0.4579 |
| Average price | $0.5484 |
| Largest weekly change | -57.0% (Aug 19, 2015) |
| Weeks tracked | 498 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tropicamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TROPICAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TROPICAMIDE 1% EYE DROPS, manufactured by Sandoz Inc., is $0.5515 per ML (NDC 61314035502), effective Sep 30, 2026.
How has the price of TROPICAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TROPICAMIDE 1% EYE DROPS has declined 44.8%. It has been tracked across 498 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TROPICAMIDE 1% EYE DROPS?
Since Nov 28, 2013, the NADAC for TROPICAMIDE 1% EYE DROPS has ranged from a low of $0.3621 (Mar 22, 2017) to a high of $1.3196 (Nov 12, 2014), with a median of $0.4579 per ML.
Are there cheaper alternatives to TROPICAMIDE 1% EYE DROPS?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TROPICAMIDE 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures TROPICAMIDE 1% EYE DROPS?
TROPICAMIDE 1% EYE DROPS (NDC 61314035502) is labeled by Sandoz Inc., and CMS classifies it as a generic product.